How many insider trades does FilingIQ track for OVID?

FilingIQ tracks 51 Form 4 insider transactions for OVID (Ovid Therapeutics Inc.), covering filings from Jun 14, 2017 onwards. 16 of those were filed in the last 90 days.

Are OVID insiders net buyers or net sellers?

Across the full Form 4 history for OVID, 13 transactions (25%) were open-market purchases and 6 (12%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does OVID insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is OVID in?

Ovid Therapeutics Inc. (OVID) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $110.74M.

OVID insider trading

NasdaqCM Healthcare

Ovid Therapeutics Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

25% / 12%

Market cap

$110.74M

About Ovid Therapeutics Inc.

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and pediatric drug-resistant epilepsies; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It develops OV350 IV, OV4071, and OV4041, an oral program that behave similarly in phenotypical screens for the treatment of psychosis in people with NSD and LBD; and OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.

Company website: www.ovidrx.com

OVID insider activity at a glance

FilingIQ has scored 51 insider transactions for OVID since Jun 14, 2017. The most recent filing in our index is dated Apr 7, 2026.

Across the full history, 13 open-market purchases and 6 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on OVID insider trades is 55.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live OVID trades on FilingIQ Raw filings on SEC EDGAR

Latest OVID Form 4 filings

ALEXANDER MARGARET A. President and CEO

S Feb 23, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading OVID

ALEXANDER MARGARET A.

3 trades · score 71.0

Frequently asked

How many insider trades does FilingIQ track for OVID?: FilingIQ tracks 51 Form 4 insider transactions for OVID (Ovid Therapeutics Inc.), covering filings from Jun 14, 2017 onwards. 16 of those were filed in the last 90 days.
Are OVID insiders net buyers or net sellers?: Across the full Form 4 history for OVID, 13 transactions (25%) were open-market purchases and 6 (12%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does OVID insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is OVID in?: Ovid Therapeutics Inc. (OVID) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $110.74M.

Methodology & sources

Every OVID insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.